Top

Annals of Nuclear Medicine

Published in:

20-01-2024 | Cytostatic Therapy | Original Article

Left ventricular mechanical dyssynchrony after chemotherapy in breast cancer patients with normal rest gated SPECT-MPI

Authors: Siamak Derakhshan, Bayazid Ghaderi, Daem Roshani

Published in: Annals of Nuclear Medicine | Issue 4/2024

Abstract

Objectives

Early diagnosis of chemotherapy-induced cardiotoxicity plays an important role in preventing heart failure. The main aim of our study was to assess left ventricular (LV) dyssynchrony measured by phase analysis of gated single-photon emission computed tomography (SPECT) as an early sign of cardiotoxicity after breast cancer chemotherapy.

Methods

This cross-sectional study was conducted on patients with stage ≤ 3 breast cancer and no history of cardiovascular disease or diabetes. After mastectomy, the patients underwent rest gated SPECT myocardial perfusion imaging (MPI). Sixty patients with normal gated SPECT-MPI were selected and the imaging was performed after chemotherapy with doxorubicin, cyclophosphamide and paclitaxel. LV function and contractility parameters were extracted by QGS software and the results were compared with the t test method. The abnormality of at least one of the three phase analysis indices was considered as left ventricular dyssynchrony (LVD).

Results

The average LV end-systolic volume and ejection fraction (LVEF) before and after chemotherapy were (16.2 ± 8.0 ml and 21.6 ± 11.6 ml) and (73.4 ± 7.9% and 67.5 ± 9.2%) respectively, which showed a significant decrease (P < 0.05). In 2 patients (3.3%), the LVEF decreased to less than 50% after chemotherapy. The average parameters of left ventricular contractility before and after chemotherapy were, respectively, as follows: PHB (24.1 ± 7.5 and 33.8 ± 16.4), PSD (9.4 ± 6.1 and 5.7 ± 1.9) and entropy (28.9 ± 7.1 and 35.6 ± 9.7), which showed a significant increase (P < 0.05). LVD was observed in 14 patients (23.4%) after chemotherapy and prevalence of LVD was significantly higher in patients who had received a cumulative dose of doxorubicin of more than 400 mg/m² (P = 0.005). There was no relationship between age and body mass index with the incidence of LVD after chemotherapy (P > 0.05).

Conclusion

Using phase analysis of gated SPECT-MPI, chemotherapy-induced LVD was seen in a significant number of patients with breast cancer, especially with a high cumulative dose of doxorubicin. LVD might indicate chemotherapy-induced cardiotoxicity before LVEF becomes abnormal.

Huang J, Chan PS, Lok V, Chen X, Ding H, Jin Y, et al. Global incidence and mortality of breast cancer: a trend analysis. Aging (Albany NY). 2021;13(4):5748–803. https://doi.org/10.18632/aging.202502.CrossRefPubMed

Kweon SS, Kim MG, Kang MR, Shin MH, Choi JS. Difference of stage at cancer diagnosis by socioeconomic status for four target cancers of the National Cancer Screening Program in Korea: Results from the Gwangju and Jeonnam cancer registries. J Epidemiol. 2017;27(7):299–304.CrossRefPubMedPubMedCentral

Denduluri N, Chavez-MacGregor M, Telli ML, Eisen A, Graff SL, Hassett MJ, et al. Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2018;36(23):2433–43. https://doi.org/10.1200/JCO.2018.78.8604.CrossRefPubMed

AlJaroudi WA, Hage FG. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance. J Nucl Cardiol. 2021;28:2100–11.CrossRefPubMedPubMedCentral

Fogarassy G, Fogarassyné Vathy Á, Kováts T, Hornyák L, Kenessey I, Veress G, et al. A doxorubicinkezeléshez kapcsolódó szívelégtelenség kialakulásának rizikótényezői a hazai országos adatbázisok integrált, retrospektív elemzése alapján [Analysing the risk factors of doxorubicin-associated heart failure by a retrospective study of integrated, nation-wide databases]. Orv Hetil. 2020;161(26):1094–102. https://doi.org/10.1556/650.2020.31739.CrossRefPubMed

Lyon RA, Habibian M, Evertz R, Asteggiano R, Suter TM. Diagnosis and treatment of left ventricular dysfunction and heart failure in cancer patients. E-J Cardiol Practice. 2019;16(40):1–22.

Soujeri B, Singh J, Chew S, Hawkey S, Ferguson M, Lang CC. Surveillance and Incidence of Chemotherapy-Induced Cardiotoxicity in Breast Cancer: A Long Term Observational Study. Heart. 2016;102(suppl 6):A14–5.CrossRef

Tajiri K, Aonuma K, Sekine I. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients. Jpn J Clin Oncol. 2017;47(8):678–82. https://doi.org/10.1093/jjco/hyx068.CrossRefPubMed

Jeyaprakash P, Sangha S, Ellenberger K, Sivapathan S, Pathan F, Negishi K. Cardiotoxic effect of modern anthracycline dosing on left ventricular ejection fraction: a systematic review and meta-analysis of placebo arms from randomized controlled trials. J Am Heart Assoc. 2021;10(6):e018802.CrossRefPubMedPubMedCentral

10.

Kolla BC, Roy SS, Duval S, Weisdorf D, Valeti U, Blaes A. Cardiac imaging methods for chemotherapy-related cardiotoxicity screening and related radiation exposure: current practice and trends. Anticancer Res. 2017;37(5):2445–9. https://doi.org/10.21873/anticanres.11584.CrossRefPubMed

11.

Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, ESC Scientific Document Group, et al. ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768–801. https://doi.org/10.1093/eurheartj/ehw211.CrossRefPubMed

12.

Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, et al. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin. 2016;66(4):309–25. https://doi.org/10.3322/caac.21341.CrossRefPubMed

13.

Marcassa C. Neuronal damage and abnormal contraction: Is the circle of synchronicity complete? J Nucl Cardiol. 2019;26(3):880–2. https://doi.org/10.1007/s12350-017-1167-6.CrossRefPubMed

14.

Bleeker GB, Bax JJ, Steendijk P, Schalij MJ, van der Wall EE. Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment. Nat Clin Pract Cardiovasc Med. 2006;3(4):213–9. https://doi.org/10.1038/ncpcardio0505.CrossRefPubMed

15.

Xu Y, Shi J, Zhao R, Zhang C, He Y, Lin J, et al. Anthracycline induced inconsistent left ventricular segmental systolic function variation in patients with lymphoma detected by three-dimensional speckle tracking imaging. Int J Cardiovasc Imaging. 2019;35(5):771–9. https://doi.org/10.1007/s10554-018-1510-2.CrossRefPubMed

16.

Singh JP, Solomon SD, Fradley MG, Barac A, Kremer KA, Beck CA, MADIT-CHIC Investigators, et al. Association of cardiac resynchronization therapy with change in left ventricular ejection fraction in patients with chemotherapy-induced cardiomyopathy. JAMA. 2019;322(18):1799–805. https://doi.org/10.1001/jama.2019.16658.CrossRefPubMedPubMedCentral

17.

Malik D, Mittal B, Sood A, Parmar M, Kaur G, Bahl A. Left ventricular mechanical dyssynchrony assessment in long-standing type II diabetes mellitus patients with normal gated SPECT-MPI. J Nucl Cardiol. 2019;26(5):1650–8. https://doi.org/10.1007/s12350-018-1208-9.CrossRefPubMed

18.

Alvandi M, Shaghaghi Z, Aryafar V, Fariba F, Sanaei Z. The evaluation of left ventricular dyssynchrony in hypertensive patients with a preserved systolic function undergoing gated SPECT myocardial perfusion imaging. Ann Nucl Med. 2019;33(12):899–906. https://doi.org/10.1007/s12149-019-01402-4.CrossRefPubMed

19.

Hess PL, Shaw LK, Fudim M, Iskandrian AE, Borges-Neto S. The prognostic value of mechanical left ventricular dyssynchrony defined by phase analysis from gated single-photon emission computed tomography myocardial perfusion imaging among patients with coronary heart disease. J Nucl Cardiol. 2017;24(2):482–90. https://doi.org/10.1007/s12350-015-0388-9.CrossRefPubMed

20.

Mori H, Isobe S, Suzuki S, Unno K, Morimoto R, Kano N, et al. Prognostic value of left ventricular dyssynchrony evaluated by gated myocardial perfusion imaging in patients with chronic kidney disease and normal perfusion defect scores. J Nucl Cardiol. 2019;26(1):288–97. https://doi.org/10.1007/s12350-017-0889-9.CrossRefPubMed

21.

Sharir T, Hollander I, Kovalski G. Can phase analysis of gated myocardial perfusion single-photon emission computed tomography predict adverse outcome in cardiac sarcoidosis? J Nucl Cardiol. 2021;28(1):137–9. https://doi.org/10.1007/s12350-019-01744-6.CrossRefPubMed

22.

Ferrando Castagnetto R, Ferrando-Castagnetto F. Towards pre-treatment imaging prediction of chemotherapy-related cardiotoxicity. J Nucl Cardiol. 2022;29:590–3. https://doi.org/10.1007/s12350-020-02368-x.CrossRefPubMed

23.

Slomka PJ, Berman DS, Xu Y, Kavanagh P, Hayes SW, Dorbala S, et al. Fully automated wall motion and thickening scoring system for myocardial perfusion SPECT: method development and validation in large population. J Nucl Cardiol. 2012;19(2):291–302. https://doi.org/10.1007/s12350-011-9502-9.CrossRefPubMedPubMedCentral

24.

Czaja-Ziółkowska MZ, Wasilewski JP, Głowacki J, Wygoda Z, Gąsior M. Useful assessment of myocardial viability and dyssynchrony from gated perfusion scintigraphy for better qualification for resynchronization therapy. Part 3. Kardiochir Torakochirurgia Pol. 2020;17(3):155–9. https://doi.org/10.5114/kitp.2020.99080.CrossRefPubMedPubMedCentral

25.

Russell RR, Alexander J, Jain D, Poornima IG, Srivastava AV, Storozynsky E, et al. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy. J Nucl Cardiol. 2016;23(4):856–84. https://doi.org/10.1007/s12350-016-0538-8.CrossRefPubMed

26.

Reuvekamp EJ, Bulten BF, Nieuwenhuis AA, Meekes MRA, de Haan AFJ, Tolet J, et al. Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA). J Nucl Cardiol. 2016;23(4):824–32. https://doi.org/10.1007/s12350-015-0164-x.CrossRefPubMed

27.

Qiu C, Lin Y, Gu W, Wang J, Shao X, Zhang F, et al. Phase analysis of gated myocardial perfusion imaging for early diagnosis of cardiotoxicity caused by anthracyclines in patients with diffuse large B-cell lymphoma. Chin J Nucl Med Mol Imaging. 2019;39(10):591–6.

28.

Jones KA, Small AD, Ray S, Hamilton DJ, Martin W, Robinson J, et al. Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy. J Nucl Cardiol. 2022;1:1–9.

29.

Valzania C, Paccagnella A, Spadotto A, Ruotolo I, Bonfiglioli R, Fallani F, et al. Early detection of cancer therapy cardiotoxicity by radionuclide angiography: an update. J Nucl Cardiol. 2023. https://doi.org/10.1007/s12350-023-03202-w.CrossRefPubMed

30.

Henriksen PA. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention. Heart. 2018;104(12):971–7. https://doi.org/10.1136/heartjnl-2017-312103.CrossRefPubMed

31.

McGowan JV, Chung R, Maulik A, Piotrowska I, Walker JM, Yellon DM. Anthracycline chemotherapy and cardiotoxicity. Cardiovasc Drugs Ther. 2017;31(1):63–75. https://doi.org/10.1007/s10557-016-6711-0.CrossRefPubMedPubMedCentral

32.

Henry ML, Niu J, Zhang N, Giordano SH, Chavez-MacGregor M. Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients. JACC Cardiovasc Imaging. 2018;11(8):1084–93. https://doi.org/10.1016/j.jcmg.2018.06.005.PMID:30092967;PMCID:PMC6149535.CrossRefPubMedPubMedCentral

Title: Left ventricular mechanical dyssynchrony after chemotherapy in breast cancer patients with normal rest gated SPECT-MPI
Authors: Siamak Derakhshan
Bayazid Ghaderi
Daem Roshani
Publication date: 20-01-2024
Publisher: Springer Nature Singapore
Keywords: Cytostatic Therapy
Breast Cancer
Breast Cancer
Anthracycline
Published in: Annals of Nuclear Medicine / Issue 4/2024
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-023-01897-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Left ventricular mechanical dyssynchrony after chemotherapy in breast cancer patients with normal rest gated SPECT-MPI

Abstract

Objectives

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2024

Performance of 99mTc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis

Nuclear medicine practice in Japan: a report of the ninth nationwide survey in 2022

Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma

Visual and whole-body quantitative analyses of 68 Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with 177Lu-DOTATATE

Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis

Correction: Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects